Julie Appleby reports on the implementation of the health care overhaul law, the interplay of health care treatments and costs, trends in health insurance, and policy issues affecting hospitals and other medical providers. Her KHN stories have appeared in USA Today, the Washington Post, the Philadelphia Inquirer and MSNBC, among others. Before joining KHN in March 2009, Appleby spent 10 years on the health care industry and policy beat for USA Today. She also worked at the San Francisco Chronicle
, the Financial Times
in London and the Contra Costa Times
in Walnut Creek, Calif. She serves on the board of the Association of Health Care Journalists and her education includes a Master of Public Health degree. | Contact: JulieA@kff.org | @Julie_Appleby
Insurers develop new business strategies as the health law upends old models.
The proposed regulations deal with several key issues, such as how plans structure their health benefits, the variations on premiums based on age and requirements for wellness programs.
Cascading delays related to technical issues could make October 2013 target for open enrollment difficult, if not impossible, to meet.
The Kaiser Permanente chairman and CEO offers his take on a wide variety of health care issues insurers face in the current marketplace.
Meningitis outbreak puts spotlight on rules favoring cheaper, but potentially riskier versions of drug to help prevent premature births.
The United States spends more on health care services than any other country, exceeding $2.6 trillion, or about 18 percent of gross domestic product. Here are seven ways you or your medical providers play a role.
The track records of two programs often cited by Republican candidates suggest a more complicated picture.
Analysts attribute slowed growth to people using less health care as a result of higher deductibles, continuing weak economy.
State experiment gets scrutiny amid national debate over role of insurance regulation in rising coverage costs.
Supporters say the $10,000 treatment is worth the cost, but others raise questions about its long-term effectiveness.